Back to results
TerminatedPhase 2

Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma

NCT03787303

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Aultman Medical Group Hematology and Oncology

Canton, Ohio, United States

View on ClinicalTrials.gov
Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma — TrialFind